Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001113423-16-000057
Filing Date
2016-11-08
Accepted
2016-11-08 17:20:07
Documents
3
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 6-K q3-2016xprx6k.htm 6-K 17163
2 EXHIBIT 99.1 exhibit991pr-q3x2016.htm EX-99.1 148886
3 logoa07.jpg GRAPHIC 91117
  Complete submission text file 0001113423-16-000057.txt   292799
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-30752 | Film No.: 161982102
SIC: 2834 Pharmaceutical Preparations